A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors

NCT07524348 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: E303

Sponsor

Samsung Bioepis Co., Ltd.